Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancer
Elevated postoperative CEA indicates worse DFS and OS in patients with HR-positive/HER2-negative early breast cancer.
Authors
- Taha Koray Şahin (ORCID: https://orcid.org/0000-0002-3590-0426)
- Sercan Aksoy (ORCID: https://orcid.org/0000-0003-4984-1049)
- Gözde Kavgacı (ORCID: https://orcid.org/0000-0001-6960-2024)
- Deniz Can Güven (ORCID: https://orcid.org/0000-0002-6924-9467)
- Serez İleri
- Tugcenur Muderrisoglu
Institutions
- Cancer Institute (WIA) (IN)
- Hacettepe University Hospital (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- Expert Review of Anticancer Therapy
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1080/14737140.2024.2443009
- Citations
- 1
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28